scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Cellular survival: a play in three Akts

15 Nov 1999-Genes & Development (Cold Spring Harbor Lab)-Vol. 13, Iss: 22, pp 2905-2927
TL;DR: The mechanisms by which survival factors regulate the PI3K/c-Akt cascade, the evidence that activation of the PI 3K/ c-AKT pathway promotes cell survival, and the current spectrum of c- akt targets and their roles in mediating c- Akt-dependent cell survival are reviewed.
Abstract: The programmed cell death that occurs as part of normal mammalian development was first observed nearly a century ago (Collin 1906). It has since been established that approximately half of all neurons in the neuroaxis and >99.9% of the total number of cells generated during the course of a human lifetime go on to die through a process of apoptosis (for review, see Datta and Greenberg 1998; Vaux and Korsmeyer 1999). The induction of developmental cell death is a highly regulated process and can be suppressed by a variety of extracellular stimuli. The purification in the 1950s of the nerve growth factor (NGF), which promotes the survival of sympathetic neurons, set the stage for the discovery that peptide trophic factors promote the survival of a wide variety of cell types in vitro and in vivo (Levi-Montalcini 1987). The profound biological consequences of growth factor (GF) suppression of apoptosis are exemplified by the critical role of target-derived neurotrophins in the survival of neurons and the maintenance of functional neuronal circuits. (Pettmann and Henderson 1998). Recently, the ability of trophic factors to promote survival have been attributed, at least in part, to the phosphatidylinositide 38-OH kinase (PI3K)/c-Akt kinase cascade. Several targets of the PI3K/c-Akt signaling pathway have been recently identified that may underlie the ability of this regulatory cascade to promote survival. These substrates include two components of the intrinsic cell death machinery, BAD and caspase 9, transcription factors of the forkhead family, and a kinase, IKK, that regulates the NF-kB transcription factor. This article reviews the mechanisms by which survival factors regulate the PI3K/c-Akt cascade, the evidence that activation of the PI3K/c-Akt pathway promotes cell survival, and the current spectrum of c-Akt targets and their roles in mediating c-Akt-dependent cell survival.

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI
13 Oct 2000-Cell
TL;DR: Understanding of the complex signaling networks downstream from RTKs and how alterations in these networks are translated into cellular responses provides an important context for therapeutically countering the effects of pathogenic RTK mutations in cancer and other diseases.

7,056 citations

Journal ArticleDOI
TL;DR: Small-molecule therapeutics that block PI3K signalling might deal a severe blow to cancer cells by blocking many aspects of the tumour-cell phenotype.
Abstract: One signal that is overactivated in a wide range of tumour types is the production of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K) This lipid and the protein kinase that is activated by it — AKT — trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumour progression Small-molecule therapeutics that block PI3K signalling might deal a severe blow to cancer cells by blocking many aspects of the tumour-cell phenotype

5,654 citations


Cites background from "Cellular survival: a play in three ..."

  • ...Foremost among these in the PIP 3 field is AKT, the cellular homologue of the retroviral oncogene v-Akt, which is also known as protein kinase B (PKB; reviewed in Ref...

    [...]

Journal ArticleDOI
TL;DR: Neurotrophins regulate development, maintenance, and function of vertebrate nervous systems, and control synaptic function and synaptic plasticity, while continuing to modulate neuronal survival.
Abstract: Neurotrophins regulate development, maintenance, and function of vertebrate nervous systems. Neurotrophins activate two different classes of receptors, the Trk family of receptor tyrosine kinases and p75NTR, a member of the TNF receptor superfamily. Through these, neurotrophins activate many signaling pathways, including those mediated by ras and members of the cdc-42/ras/rho G protein families, and the MAP kinase, PI-3 kinase, and Jun kinase cascades. During development, limiting amounts of neurotrophins function as survival factors to ensure a match between the number of surviving neurons and the requirement for appropriate target innervation. They also regulate cell fate decisions, axon growth, dendrite pruning, the patterning of innervation and the expression of proteins crucial for normal neuronal function, such as neurotransmitters and ion channels. These proteins also regulate many aspects of neural function. In the mature nervous system, they control synaptic function and synaptic plasticity, while continuing to modulate neuronal survival.

3,968 citations


Cites background from "Cellular survival: a play in three ..."

  • ...Another demonstrated target of Akt is IκB (reviewed in Datta et al 1999)....

    [...]

  • ...…kinases, phosphatidyl inositides generated by PI-3 kinase activate the protein kinase Akt/protein kinase B. Akt then phosphorylates and controls the biological functions of several proteins important in modulating cell survival (reviewed in Datta et al 1999, Yuan & Yankner 2000)....

    [...]

  • ...Many additional proteins in the cell death cascade, including Bcl-2, Apaf-1, caspase inhibitors, and caspases, have a consensus site for Akt phosphorylation but have not been shown to be phosphorylated by this kinase (Datta et al 1999)....

    [...]

Journal ArticleDOI
17 May 2001-Nature
TL;DR: How oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity is emphasized and an update is provided on the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signalling in human malignancies.
Abstract: Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans Their activity is normally tightly controlled and regulated Perturbation of PTK signalling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signalling This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signalling in human malignancies

3,691 citations


Cites background from "Cellular survival: a play in three ..."

  • ...The anti-apoptotic effects of Akt-mediated phosphorylation of these have been extensively reviewe...

    [...]

Journal ArticleDOI
TL;DR: This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signalling of DNA damage, cell-cycle checkpoints and arrest, DNA repair and cell death.
Abstract: Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in cancer chemotherapy. Platinum–DNA adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs. This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signalling of DNA damage, cell-cycle checkpoints and arrest, DNA repair and cell death. Such knowledge of the cellular processing of cisplatin adducts with DNA provides valuable clues for the rational design of more efficient platinum-based drugs as well as the development of new therapeutic strategies.

3,254 citations

References
More filters
Journal ArticleDOI
28 Aug 1998-Science
TL;DR: A variety of key events in apoptosis focus on mitochondria, including the release of caspase activators (such as cytochrome c), changes in electron transport, loss of mitochondrial transmembrane potential, altered cellular oxidation-reduction, and participation of pro- and antiapoptotic Bcl-2 family proteins.
Abstract: A variety of key events in apoptosis focus on mitochondria, including the release of caspase activators (such as cytochrome c), changes in electron transport, loss of mitochondrial transmembrane potential, altered cellular oxidation-reduction, and participation of pro- and antiapoptotic Bcl-2 family proteins. The different signals that converge on mitochondria to trigger or inhibit these events and their downstream effects delineate several major pathways in physiological cell death.

8,757 citations

Journal ArticleDOI
19 Nov 1993-Cell
TL;DR: A gene is identified, named WAF1, whose induction was associated with wild-type but not mutant p53 gene expression in a human brain tumor cell line and that could be an important mediator of p53-dependent tumor growth suppression.

8,339 citations

Journal ArticleDOI
19 Mar 1999-Cell
TL;DR: It is demonstrated that Akt also regulates the activity of FKHRL1, a member of the Forkhead family of transcription factors, which triggers apoptosis most likely by inducing the expression of genes that are critical for cell death, such as the Fas ligand gene.

6,481 citations


"Cellular survival: a play in three ..." refers background in this paper

  • ...Electrophoretic mobility shift assays indicate that AFX, FKHR, and FKHRL1 bind to the IRS within the IGFBP1 promoter (Brunet et al. 1999; Kops et al. 1999; Tang et al. 1999)....

    [...]

  • ...The expression of a constitutively active version of Akt within cells is sufficient to induce the phosphorylation of all three Forkhead isoforms at all three sites (Biggs et al. 1999; Brunet et al. 1999; Kops et al. 1999; Rena et al. 1999)....

    [...]

  • ...Since, like BAD, FKHRL1 has been shown to interact with 14-3-3 proteins (Brunet et al. 1999), 14-3-3 may serve as a general chaperone molecule for Akt targets, and may participate in the anchoring of the phosphorylated form of Forkhead transcription factors within the cytoplasm....

    [...]

  • ...bers in the cytoplasm has functional consequences for Forkhead-dependent transcription (Biggs et al. 1999; Brunet et al. 1999; Guo et al. 1999; Kops et al. 1999; Tang et al. 1999)....

    [...]

  • ...Consistent with this idea, the induction of apoptosis that is triggered by the FKHRL1 phosphorylation site mutant can be reverted when FKHRL1 mutant expressing cells are treated with a soluble form of Fas that acts as a decoy receptor for the newly-synthesized FasL (Brunet et al. 1999)....

    [...]

Journal ArticleDOI
17 Oct 1997-Cell
TL;DR: It is shown that growth factor activation of the PI3'K/Akt signaling pathway culminates in the phosphorylation of the BCL-2 family member BAD, thereby suppressing apoptosis and promoting cell survival.

5,831 citations


"Cellular survival: a play in three ..." refers background in this paper

  • ...Several kinases, including PKA, Ca/CaMKII, Ca/CaMK IV, and pp90s, phosphorylate Bad in vitro (Datta et al. 1997; Bonni et al. 1999)....

    [...]

  • ...In addition, transfection of 3T3 cells with active Akt alleles is sufficient to induce the phosphorylation of endogenous Bad at Ser-136 (Datta et al. 1997), whereas transfection of cells with dominant–negative Akt alleles blocks phosphorylation of transfected Bad at Ser-136 (Datta et al. 1997; Del…...

    [...]

  • ...Consistent with the direct regulation of Bad by Akt, both Bad and Akt coimmunoprecipitate when overexpressed and interact in GST-pulldown experiments (Datta et al. 1997; Blume-Jensen et al. 1998)....

    [...]

  • ...…with active Akt alleles is sufficient to induce the phosphorylation of endogenous Bad at Ser-136 (Datta et al. 1997), whereas transfection of cells with dominant–negative Akt alleles blocks phosphorylation of transfected Bad at Ser-136 (Datta et al. 1997; Del Peso et al. 1997; Wang et al. 1999a)....

    [...]

  • ...These sites also both lie within consensus sequences that correspond to the Akt phosphorylation site, and Akt was found to potently phosphorylate Bad in vitro (Datta et al. 1997; Del Peso et al. 1997)....

    [...]

Journal ArticleDOI
24 Nov 1995-Science
TL;DR: The effects of dominant-interfering or constitutively activated forms of various components of the JNK-p38 and ERK signaling pathways demonstrated that activation of JNK and p38 and concurrent inhibition of ERK are critical for induction of apoptosis in these cells.
Abstract: Apoptosis plays an important role during neuronal development, and defects in apoptosis may underlie various neurodegenerative disorders. To characterize molecular mechanisms that regulate neuronal apoptosis, the contributions to cell death of mitogen-activated protein (MAP) kinase family members, including ERK (extracellular signal-regulated kinase), JNK (c-JUN NH2-terminal protein kinase), and p38, were examined after withdrawal of nerve growth factor (NGF) from rat PC-12 pheochromocytoma cells. NGF withdrawal led to sustained activation of the JNK and p38 enzymes and inhibition of ERKs. The effects of dominant-interfering or constitutively activated forms of various components of the JNK-p38 and ERK signaling pathways demonstrated that activation of JNK and p38 and concurrent inhibition of ERK are critical for induction of apoptosis in these cells. Therefore, the dynamic balance between growth factor-activated ERK and stress-activated JNK-p38 pathways may be important in determining whether a cell survives or undergoes apoptosis.

5,398 citations


"Cellular survival: a play in three ..." refers background in this paper

  • ...It is now clear that the Raf–MEK– MAPK cascade does under some circumstances promote cell survival (Xia et al. 1995; Parrizas et al. 1997; Bergmann et al. 1998; Kurada and White 1998; Meier and Evan 1998; Anderson and Tolkovsky 1999; Bonni et al. 1999; Shimamura et al. 1999)....

    [...]